Apremilast Spirig HC 30 mg

Apremilast Spirig HC 30 mg is a medicine authorised by Swissmedic under authorisation number 69555. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 July 2025 and the authorisation is limited until 21 July 2030. ATC code L04AA32 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 69555
  • ATC L04AA32
  • Synthetic medicines
Authorisation data
Authorisation number69555
NameApremilast Spirig HC 30 mg
Full nameApremilast Spirig HC 30 mg, Filmtabletten
Authorisation holderSpirig HealthCare AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL04AA32
First authorisation22 July 2025
Authorisation validity21 July 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Apremilast Spirig HC 30 mg, FilmtablettenB22 July 2025
2Apremilast Spirig HC 10 mg / 20 mg / 30 mg, FilmtablettenB22 July 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)L04AA3207.15.0.B
2168Tablette(n)L04AA3207.15.0.B
34 + 4 + 19Tablette(n)L04AA3207.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Apremilast Spirig HC 30 mg authorised in Switzerland?

Yes. Apremilast Spirig HC 30 mg is authorised by Swissmedic under authorisation number 69555, data as of 01 September 2026. The authorisation is limited until 21 July 2030.

Which dispensing category does Apremilast Spirig HC 30 mg have?

Apremilast Spirig HC 30 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Apremilast Spirig HC 30 mg?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com